ANTIPLATELET AND ANTICOAGULANT THERAPY IN THE SECONDARY PREVENTION OF ISCHEMIC HEART DISEASE
- 1 January 2000
- journal article
- review article
- Published by Elsevier in Medical Clinics of North America
- Vol. 84 (1), 163-179
- https://doi.org/10.1016/s0025-7125(05)70212-1
Abstract
No abstract availableKeywords
This publication has 76 references indexed in Scilit:
- Platelet activation in patients after an acute coronary syndrome: results from the TIMI-12 trialJournal of the American College of Cardiology, 1999
- Acute Coronary Syndromes in the GUSTO-IIb TrialCirculation, 1998
- Thrombotic thrombocytopenic purpura after stenting and ticlopidineThe Lancet, 1998
- TIMI 11B. Enoxaparin versus unfractionated heparin for unstable angina or non–Q-wave myocardial infarction: A double-blind, placebo-controlled, parallel-group, multicenter trial. Rationale, study design, and methodsAmerican Heart Journal, 1998
- Underutilization of Aspirin in Older Patients with Prior Myocardial Infarction at the Time of Admission to a Nursing HomeJournal of the American Geriatrics Society, 1998
- Antiplatelet Agents and Survival: A Cohort Analysis From the Studies of Left Ventricular Dysfunction (SOLVD) TrialJournal of the American College of Cardiology, 1998
- Effect of Ticlopidine on the Long-Term Patency of Saphenous-Vein Bypass Grafts in the LegsNew England Journal of Medicine, 1997
- Efficacy of ticlopidine and aspirin for prevention of reversible cerebrovascular ischemic events. The Ticlopidine Aspirin Stroke Study.Stroke, 1993
- Antiplatelet treatment with ticlopidine in unstable angina. A controlled multicenter clinical trial. The Studio della Ticlopidina nell'Angina Instabile Group.Circulation, 1990
- Aspirin and dipyridamole in the prevention of acute coronary thrombosis complicating coronary angioplasty.Circulation, 1987